Peptide derived from cow's milk kills human stomach cancer cells in culture
Friday, November 8, 2013 - 09:30
in Health & Medicine
New research indicates that a peptide fragment derived from cow's milk, known as lactoferricin B25 (LFcinB25), exhibited potent anticancer capability against human stomach cancer cell cultures. The findings provide support for future use of LFcinB25 as a potential therapeutic agent for gastric cancer.